Target type: biologicalprocess
Any process that modulates the occurrence or rate of cell death by apoptosis that results in the maintenance of the steady-state number of cells within a tissue. [GOC:dph]
Apoptosis, or programmed cell death, is a tightly regulated process essential for maintaining tissue homeostasis. It involves a series of biochemical events that lead to the dismantling of the cell without causing inflammation. This process is critical for normal development, tissue remodeling, and eliminating damaged or unwanted cells. Dysregulation of apoptosis can contribute to various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.
The regulation of apoptosis involves complex signaling pathways triggered by a variety of stimuli, including:
* **Intrinsic pathway:** This pathway is activated by intracellular stress signals like DNA damage, hypoxia, and growth factor deprivation. The key players in this pathway are the Bcl-2 family proteins, which regulate the release of cytochrome c from mitochondria. Cytochrome c activates caspase-9, leading to a cascade of caspase activation, ultimately resulting in cell death.
* **Extrinsic pathway:** This pathway is triggered by extracellular signals like death ligands, such as TNF-α and Fas ligand. These ligands bind to their respective receptors, activating caspase-8, which then activates caspase-3, leading to apoptosis.
* **Other pathways:** Other pathways, such as those involving granzyme B and the p53 protein, also contribute to the regulation of apoptosis.
Regulation of apoptosis is crucial for maintaining tissue homeostasis. It ensures that:
* **Development and growth:** Apoptosis plays a critical role in sculpting organs and tissues during embryonic development.
* **Tissue repair:** Damaged cells are eliminated via apoptosis, allowing for proper wound healing and tissue regeneration.
* **Immune system regulation:** Apoptosis eliminates self-reactive immune cells, preventing autoimmune diseases.
* **Elimination of unwanted cells:** Cells that have completed their function or are damaged are removed through apoptosis.
The regulation of apoptosis is a complex and delicate balance. Dysregulation of apoptosis can lead to pathological consequences, such as:
* **Cancer:** Increased cell survival due to reduced apoptosis can promote tumor growth.
* **Neurodegenerative diseases:** Excessive apoptosis of neurons contributes to the progression of Alzheimer's disease and Parkinson's disease.
* **Autoimmune diseases:** Reduced apoptosis of self-reactive immune cells can lead to autoimmune disorders.
Understanding the intricate mechanisms of apoptosis regulation is crucial for developing therapeutic strategies for various diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
E3 ubiquitin-protein ligase XIAP | A baculoviral IAP repeat-containing protein 4 that is encoded in the genome of human. [PRO:CNA, UniProtKB:P98170] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
embelin | embelin : A member of the class of dihydroxy-1,4-benzoquinones that is 2,5-dihydroxy-1,4-benzoquinone which is substituted by an undecyl group at position 3. Isolated from Lysimachia punctata and Embelia ribes, it exhibits antimicrobial, antineoplastic and inhibitory activity towards hepatitis C protease. embelin: from Embelia fruit (Myrsinaceae) | dihydroxy-1,4-benzoquinones | antimicrobial agent; antineoplastic agent; hepatitis C protease inhibitor; plant metabolite |
phenylalanine | L-phenylalanine : The L-enantiomer of phenylalanine. phenylalanine : An aromatic amino acid that is alanine in which one of the methyl hydrogens is substituted by a phenyl group. Phenylalanine: An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE. | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; phenylalanine; proteinogenic amino acid | algal metabolite; EC 3.1.3.1 (alkaline phosphatase) inhibitor; Escherichia coli metabolite; human xenobiotic metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
kaempferol | 7-hydroxyflavonol; flavonols; tetrahydroxyflavone | antibacterial agent; geroprotector; human blood serum metabolite; human urinary metabolite; human xenobiotic metabolite; plant metabolite | |
kaempferol 3-o-rhamnoside | afzelin : A glycosyloxyflavone that is kaempferol attached to an alpha-L-rhamnosyl residue at position 3 via a glycosidic linkage. kaempferol 3-O-rhamnoside: from apple (Malus domestica) leaves; structure in first source | glycosyloxyflavone; monosaccharide derivative; trihydroxyflavone | anti-inflammatory agent; antibacterial agent; plant metabolite |
lbw242 | LBW242: proapoptotic IAP inhibitor; low MW Smac (Second mitochondria-derived activator of caspases) mimetic; structure in first source | ||
sm 164 | SM 164: a bivalent Smac mimetic with antineoplastic activity; structure in first source | benzenes; organic heterobicyclic compound; secondary carboxamide; triazoles | antineoplastic agent; apoptosis inducer; radiosensitizing agent |
lcl161 | 1,3-thiazoles; aromatic ketone; L-alanine derivative; monofluorobenzenes; N-acylpyrrolidine | antineoplastic agent; apoptosis inducer | |
at 406 | |||
gdc-0152 | GDC-0152: structure in first source | ||
birinapant | birinapant: a Smac mimetic with antineoplastic activity | dipeptide | |
nvp-cgm097 | NVP-CGM097: an MDM2 and HDM2 inhibitor; structure in first source | ||
2-carboxyarabinitol 1-phosphate |